Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | LCK | P06239 | 1/20 | 0.59 |
| ▸ | PPARD | Q03181 | 1/20 | 0.59 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.59 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.59 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.55 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.55 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.50 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.50 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.49 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.49 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.49 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5920648 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL17786 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7990074 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL524846 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL338215 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7309478 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL123324 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL4424351 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL6242099 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL6238780 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4139388-A1 | USE OF HYDROXYCARBOXYLIC ACID SALTS FOR STABILIZING THERMOPLASTIC CONDENSATION POLYMERS, STABILIZED MOULDING COMPOSITIONS AND MOULDING COMPOSITIONS PRODUCED THEREFROM | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2023-03-01 | — | — | EP | claimed |
| EP-4139387-A1 | ADDITIVE COMPOSITION AND USE THEREOF, CONDENSATION POLYMER COMPOSITION, MOLDING COMPOUND AND MOLDING COMPOUNDS PRODUCED THEREFROM, AND MOLDED PARTS AND USE THEREOF | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2023-03-01 | — | — | EP | claimed |
| CN-115461396-A | Additive composition and use thereof, condensation polymer composition, moulding compound and moulded part produced therefrom and use thereof | 弗劳恩霍夫应用研究促进协会 | 2022-12-09 | — | — | CN | claimed |
| WO-2021214207-A1 | USE OF HYDROXYCARBOXYLIC ACID SALTS FOR STABILIZING THERMOPLASTIC CONDENSATION POLYMERS, STABILIZED MOULDING COMPOSITIONS AND MOULDING COMPOSITIONS PRODUCED THEREFROM | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2021-10-28 | — | — | WO | claimed |
| WO-2021213939-A1 | ADDITIVE COMPOSITION AND USE THEREOF, CONDENSATION POLYMER COMPOSITION, MOLDING COMPOUND AND MOLDING COMPOUNDS PRODUCED THEREFROM, AND MOLDED PARTS AND USE THEREOF | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2021-10-28 | — | — | WO | claimed |
| US-12534651-B2 | Electrically conductive adhesive, sintered body of electrically conductive adhesive, method for producing sintered body, electronic component, and method for producing electronic component | THE SCHOOL CORPORATION KANSAI UNIVERSITY (JP) | 2026-01-27 | — | — | US | disclosed |
| US-12441917-B2 | Electroconductive adhesive | OSAKA SODA CO., LTD. (JP) | 2025-10-14 | — | — | US | disclosed |
| EP-4596143-A1 | SILVER PARTICLES | Osaka Soda Co., Ltd. (JP) | 2025-08-06 | — | — | EP | disclosed |
| EP-4596144-A1 | SILVER PARTICLES | Osaka Soda Co., Ltd. (JP) | 2025-08-06 | — | — | EP | disclosed |
| US-12257631-B2 | Silver nanoparticles | OSAKA SODA CO., LTD (JP) | 2025-03-25 | — | — | US | disclosed |
| WO-2025053053-A1 | SILVER PARTICLES | 株式会社大阪ソーダ | 2025-03-13 | — | — | WO | disclosed |
| US-20250084286-A1 | ELECTROCONDUCTIVE ADHESIVE | OSAKA SODA CO., LTD. (JP) | 2025-03-13 | — | — | US | disclosed |
| WO-2014144777-A2 | LIPIDS THAT INCREASE INSULIN SENSITIVITY AND METHODS OF USING THE SAME | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2014-09-18 | — | — | WO | disclosed |
| WO-2013166431-A1 | LIPIDS THAT INCREASE INSULIN SENSITIVITY AND METHODS OF USING THE SAME | BETH ISREAL DEACONESS MEDICAL CENTER, INC. (US) | 2013-11-07 | — | — | WO | disclosed |
| EP-2598553-A1 | COMPOSITIONS COMPRISING POLYMERS PREPARED FROM 2-HYDROXYALKYL ACIDS | Université de Genève (CH) | 2013-06-05 | — | — | EP | disclosed |
| US-20130131190-A1 | COMPOSITIONS COMPRISING POLYMERS PREPARED FROM 2-HYDROXYALKYL ACIDS | UNIVERSITE DE GENEVE (CH) | 2013-05-23 | — | — | US | disclosed |
| WO-2012014011-A1 | COMPOSITIONS COMPRISING POLYMERS PREPARED FROM 2-HYDROXYALKYL ACIDS | UNIVERSITE DE GENEVE (CH) | 2012-02-02 | — | — | WO | disclosed |
| EP-0875232-B1 | A lipid composition containing liquid crystal phase | TAKASAGO PERFUMERY CO LTD (JP) | 2002-02-13 | — | — | EP | disclosed |
| US-5916578-A | 2-ACETAMINOALKANE-1,3-DIOL OR ITS OPTICAL ISOMER, STEROL, MOISTURIZERS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1999-06-29 | — | — | US | disclosed |
| EP-0875232-A1 | A lipid composition containing liquid crystal phase | Takasago International Corporation (JP) | 1998-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130131190-A1 | COMPOSITIONS COMPRISING POLYMERS PREPARED FROM 2-HYDROXYALKYL ACIDS | HACL2, CRYAA, HDHD5 | GPR84 4129/4885FFAR1 2013/4885MAPT 2146/4885 |
| US-12534651-B2 | Electrically conductive adhesive, sintered body of electrically conductive adhesive, method for producing sintered body, electronic component, and method for producing electronic component | GJA1, EPCAM, GJB2 | GPR84 2015/4885FFAR1 795/4885MAPT 2398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.